
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.62 | -9.62732919255 | 6.44 | 6.88 | 5.82 | 270075 | 6.23251459 | CS |
4 | -1.37 | -19.0542420028 | 7.19 | 7.3 | 5.82 | 224952 | 6.60238187 | CS |
12 | -3.71 | -38.9296956978 | 9.53 | 9.99 | 5.82 | 288263 | 7.86608981 | CS |
26 | -5.42 | -48.2206405694 | 11.24 | 12.92 | 5.82 | 310032 | 9.72252002 | CS |
52 | -8.57 | -59.5552466991 | 14.39 | 16.9 | 5.82 | 487466 | 11.09065584 | CS |
156 | -0.7 | -10.736196319 | 6.52 | 16.9 | 2.36 | 329677 | 10.38205954 | CS |
260 | -2.71 | -31.7702227433 | 8.53 | 16.9 | 2.36 | 290666 | 10.28024627 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約